DoD Gulf War Illness, Patient-Provider and Health Communications Award | W81XWH 20 GWIRP PPHCA

Opportunity Information: Apply for W81XWH 20 GWIRP PPHCA

The DoD Gulf War Illness (GWIRP) Patient-Provider and Health Communications Award (FY20) is a funding opportunity from the Department of Defense (U.S. Army Medical Research Acquisition Activity) focused on improving how credible, evidence-based Gulf War Illness (GWI) research and clinical information is communicated to the people who need it most. Rather than funding laboratory studies or new clinical trials, this award is built around creating and implementing practical communication tools, platforms, and dissemination processes that raise awareness and understanding of GWI findings across key communities. The central idea is to shorten the distance between what research is discovering (at any stage in the research pipeline) and what Veterans, caregivers, clinicians, and public health professionals actually know and can use.

A major emphasis of the award is near-term, real-world impact on quality of life for Veterans living with GWI. Funded projects are expected to make it easier for Veterans and caregivers to find trustworthy, up-to-date information, and to help healthcare providers and other professionals understand the current state of the science so they can communicate more effectively about GWI, potential treatments, and day-to-day management. The opportunity also highlights the need to address and reduce stigma and other barriers that may prevent serious engagement with GWI, whether those barriers are professional, personal, or institutional.

A defining requirement is meaningful Gulf War Veteran involvement. Every application must include at least one Gulf War Veteran who has GWI, and that Veteran must be integrated throughout planning and execution, not used as a symbolic advisor. The Veteran is expected to help shape the research idea, guide the project design, contribute to oversight, and participate in evaluation so the final product is genuinely useful to the GWI community. The announcement is explicit that the interaction should be ongoing and deeply embedded in the work, not limited to occasional attendance at meetings. It also requires the Veteran role to be independent of employment with participating organizations, although the Veteran may be paid as a consultant or collaborator. In practice, the Veteran is positioned as an objective, knowledgeable partner who can assess whether the proposed communication strategy and deliverables will truly matter to people living with GWI, especially given real clinical care challenges and gaps in existing information pathways.

On the content and design side, proposals need to lay out a clear health communication and dissemination strategy. Applicants must identify one or more target audiences within the broader GWI community and explain the specific information gaps and needs for that audience. The eligible target groups include: (1) Veterans with GWI, (2) caregivers of Veterans with GWI, (3) healthcare providers who serve Veterans with GWI, and/or (4) public health professionals relevant to Veterans with GWI. The strategy must be practical and well-justified, including thoughtful decisions about the best channels to reach the intended audience, such as digital platforms, media approaches, organizational partnerships, or other dissemination venues. If the target audience includes health professionals, the application needs to include a well-reasoned plan for engagement and participation, recognizing that clinician adoption often requires tailored outreach, workflow fit, and clear value.

The award also expects applicants to treat dissemination as a quality-controlled process, not just broadcasting information. Proposals must include a method for evaluating and ranking GWI research or clinical information before it is shared, with attention to how evidence will be continuously updated as the science evolves. In addition, applicants must build in ongoing assessment using concrete metrics to measure whether the communication tool is working. Examples include pre- and post-intervention knowledge checks, or tracking changes in clinical practice behaviors, patient decision-making, or caregiver confidence. The program encourages feedback loops that allow continuous improvement based on input from the community using the tool.

Sustainability is another required feature. Applicants need to provide evidence of the partnerships, organizational commitments, processes, or agreements that would keep the communication platform or resource alive after the award ends. In other words, the DoD is not only looking for a one-time product, but for a communication approach that can be maintained and continue delivering value beyond the funded period.

The announcement provides illustrative examples of similar health information resources used in other disease areas, such as expert-reviewed treatment scoring platforms (e.g., ALS Untangled), disease-focused educational sites with research updates and patient experiences (e.g., BrainMetsBC.org), clinical trial matching and education portals (e.g., BreastCancerTrials.org), and web-based caregiver training programs (e.g., ImPACT Online). These examples are not endorsements, but they show the kinds of credible, structured, user-oriented dissemination models applicants might adapt for the GWI community.

The opportunity also clearly states what it will not fund. It does not support projects that frame psychiatric disease or psychological stress as the primary cause of GWI, nor does it support implementing care guidelines that place major emphasis on psychiatric pathologies or psychiatric remedies. It also does not support ALS-focused research; however, Veterans who have ALS may be included only if ALS is part of the project’s GWI case definition and the work is focused on GWI symptomatology rather than ALS as the main topic. Finally, clinical trials are not allowed under this mechanism. The announcement defines a clinical trial in standard terms (prospective assignment of human subjects to interventions to evaluate outcomes) and directs trial-focused investigators to other GWIRP award mechanisms intended for clinical evaluation or therapeutic/biomarker trials.

From an administrative and funding standpoint, this is a discretionary federal funding opportunity (CFDA 12.420) that can be awarded as a grant or cooperative agreement, and eligibility is described as unrestricted (open to entity types, subject to any additional eligibility notes in the full announcement). For budgeting, the anticipated direct costs for the entire period of performance may not exceed $600,000. Program leadership expected to allocate roughly $960,000 total to fund approximately one award, meaning it is a highly competitive mechanism with a small number of funded projects. Key timeline details in the posted announcement include an original closing date of September 10, 2020, and an award target of no later than September 30, 2021, with FY20 funds anticipated to expire for use on September 30, 2026 (which matters for the government’s obligation and period of availability of the funds).

Overall, the Patient-Provider and Health Communications Award is essentially a translation-and-uptake program for Gulf War Illness: it funds the development of credible, sustainable communication systems that help Veterans, caregivers, clinicians, and public health professionals stay accurately informed about GWI research and clinical knowledge, and then verifies through evaluation metrics that the communication approach actually changes understanding, engagement, and real-world practice.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Gulf War Illness, Patient-Provider and Health Communications Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Mar 24, 2020.
• Applicants must submit their applications by Sep 10, 2020. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 20 GWIRP PPHCA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: